Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation.
Vallet N, Le Grand S, Bondeelle L, Hoareau B, Corneau A, Bouteiller D, Tournier S, Derivry L, Bohineust A, Tourret M, Gibert D, Mayeur E, Itzykson R, Pacchiardi K, Ingram B, Cassonnet S, Lepage P, Peffault de Latour R, Socié G, Bergeron A, Michonneau D. Vallet N, et al. Blood. 2022 Dec 8;140(23):2500-2513. doi: 10.1182/blood.2022016926. Blood. 2022. PMID: 35984904 Free article. Clinical Trial.
Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital.
Vallet N, Chevret S, Feghoul L, Aguinaga L, Bondeelle L, Kaphan E, Bertinchamp R, Soret J, Villesuzanne C, De Castro N, Sebert M, Boutboul D, Lengline E, Tudesq JJ, Rabian F, Adès L, Xhaard A, Di Blasi R, Raffoux E, Galicier L, Le Goff J, Delaugerre C, Bergeron A, Harel S; Saint-Louis CORE group. Vallet N, et al. Blood Cancer J. 2021 Jul 14;11(7):129. doi: 10.1038/s41408-021-00512-5. Blood Cancer J. 2021. PMID: 34262018 Free PMC article. No abstract available.
Operational tolerance after hematopoietic stem cell transplantation is characterized by distinct transcriptional, phenotypic, and metabolic signatures.
Dubouchet L, Todorov H, Seurinck R, Vallet N, Van Gassen S, Corneau A, Blanc C, Zouali H, Boland A, Deleuze JF, Ingram B, de Latour RP, Saeys Y, Socié G, Michonneau D. Dubouchet L, et al. Among authors: vallet n. Sci Transl Med. 2022 Feb 23;14(633):eabg3083. doi: 10.1126/scitranslmed.abg3083. Epub 2022 Feb 23. Sci Transl Med. 2022. PMID: 35196024
Hematopoietic stem cell transplantation for patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a retrospective study of 21 patients from SFGM-TC centers.
Vallet N, de Fontbrune FS, Loschi M, Desmier D, Villate A, Barraco F, Chevallier P, Terriou L, Yakoub-Agha I, Ruggeri A, Mohty M, Maillard N, Rohrlich PS, Ceballos P, Nguyen S, Poiré X, Guillerm G, Tabrizi R, Farhi J, Devillier R, Rubio MT, Socié G, de Latour RP; Société Francophone de Greffe de Moelle et Thérapie Cellulaire. Vallet N, et al. Haematologica. 2018 Mar;103(3):e103-e105. doi: 10.3324/haematol.2017.182360. Epub 2017 Dec 21. Haematologica. 2018. PMID: 29269526 Free PMC article. No abstract available.
BAM conditioning before autologous transplantation for lymphoma: a study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).
Cornillon J, Daguenet E, Bay JO, Chauchet A, Salles G, Contentin N, Nicolas-Virelizier E, Mercier M, Vallet N, Alexis M, Chrétien ML, Cluzeau T, Huynh A, Himberlin C, Dorvaux V, Amorim S, Lejeune C, de Latour RP, Gyan E. Cornillon J, et al. Among authors: vallet n. Ann Hematol. 2019 Aug;98(8):1973-1980. doi: 10.1007/s00277-019-03704-z. Epub 2019 May 20. Ann Hematol. 2019. PMID: 31111177
Hypercalcemia is associated with a poor prognosis in lymphoma a retrospective monocentric matched-control study and extensive review of published reported cases.
Vallet N, Ertault M, Delaye JB, Chalopin T, Villate A, Drieu La Rochelle L, Lejeune J, Foucault A, Eloit M, Barin-Le Guellec C, Hérault O, Colombat P, Gyan E. Vallet N, et al. Ann Hematol. 2020 Feb;99(2):229-239. doi: 10.1007/s00277-019-03890-w. Epub 2020 Jan 6. Ann Hematol. 2020. PMID: 31907572 Review.
Characteristics, combinations, treatments, and survival of second primary hematological neoplasm: a retrospective single-center cohort of 49 patients (Hemo2study).
Chalopin T, Vallet N, Arbion F, Barin C, Rault E, Villate A, Eloit M, La Rochelle LD, Foucault A, Ertault M, Dartigeas C, Benboubker L, Estienne MH, Domenech J, Hérault O, Gyan E. Chalopin T, et al. Among authors: vallet n. Ann Hematol. 2019 Oct;98(10):2367-2377. doi: 10.1007/s00277-019-03778-9. Epub 2019 Aug 27. Ann Hematol. 2019. PMID: 31455988 Clinical Trial.
36 results